|
|
|
Volumn 23, Issue 6 SUPPL. 15, 1996, Pages 21-25
|
|
Combinations of paclitaxel and etoposide in the treatment of lung cancer
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CYTOCHROME P450;
ETOPOSIDE;
PACLITAXEL;
ADULT;
AGED;
ARTICLE;
BONE MARROW SUPPRESSION;
BREAST CANCER;
CELL GROWTH;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CLONOGENIC ASSAY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOSE CALCULATION;
DRUG ANTAGONISM;
DRUG CYTOTOXICITY;
DRUG POTENTIATION;
GROWTH INHIBITION;
HUMAN;
HUMAN CELL;
INTRAVENOUS DRUG ADMINISTRATION;
LUNG CANCER;
MUCOSA INFLAMMATION;
ORAL DRUG ADMINISTRATION;
PHASE 1 CLINICAL TRIAL;
PRIORITY JOURNAL;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARCINOMA, SMALL CELL;
DRUG SCREENING ASSAYS, ANTITUMOR;
ETOPOSIDE;
HUMANS;
LUNG NEOPLASMS;
MIDDLE AGED;
PACLITAXEL;
TUMOR CELLS, CULTURED;
|
|
EID: 0030512947
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (7)
|
|
References (33)
|
